On 3–8 June 2022, the First International Aegean Conference on Mesenchymal Cells in Health & Disease took place in Chania, Crete, and brought together clinicians and scientists who work on mesenchymal or stromal cell biology across different fields including immunity, inflammation and cancer.
References
Koliaraki, V., Prados, A., Armaka, M. & Kollias, G. Nat. Immunol. 21, 974–982 (2020).
Davidson, S. et al. Nat. Rev. Immunol. 21, 704–717 (2021).
Lütge, M., Pikor, N. B. & Ludewig, B. Immunol. Rev. 302, 32–46 (2021).
Korsunsky, I. et al. Med. (N Y) 3, 481–518.e414 (2022).
Chen, Y., McAndrews, K. M. & Kalluri, R. Nat. Rev. Clin. Oncol. 18, 792–804 (2021).
Biffi, G. et al. Cancer Discov. 9, 282–301 (2019).
Armaka, M. et al. J. Exp. Med. 205, 331–337 (2008).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koliaraki, V., Dotto, GP., Buckley, C.D. et al. Mesenchymal cells in health and disease. Nat Immunol 23, 1395–1398 (2022). https://doi.org/10.1038/s41590-022-01318-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-022-01318-8
- Springer Nature America, Inc.
This article is cited by
-
ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation
Nature Communications (2024)
-
Post-transcriptional checkpoints in autoimmunity
Nature Reviews Rheumatology (2023)